| Product NDC: | 0409-2122 |
| Proprietary Name: | Enalaprilat |
| Non Proprietary Name: | ENALAPRILAT |
| Active Ingredient(s): | 1.25 mg/mL & nbsp; ENALAPRILAT |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-2122 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075458 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090915 |
| Package NDC: | 0409-2122-13 |
| Package Description: | 1 VIAL in 1 CARTON (0409-2122-13) > 1 mL in 1 VIAL |
| NDC Code | 0409-2122-13 |
| Proprietary Name | Enalaprilat |
| Package Description | 1 VIAL in 1 CARTON (0409-2122-13) > 1 mL in 1 VIAL |
| Product NDC | 0409-2122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ENALAPRILAT |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090915 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | ENALAPRILAT |
| Strength Number | 1.25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |